Production
-
Showcasing A Scalable Downstream Platform For Multiple AAV Serotypes
10/10/2024
Watch to explore how to maximize AAV full capsid recovery, establish a scalable platform for various serotypes, and utilize analytical tools to measure empty/full capsid ratios and AAV titers.
-
How An Optimized Purification Platform Can Speed mAbs Clinical Production
4/3/2023
Explore how a purification development platform, including a mixed-mode chromatography step, allowed Igyxos Biotherapeutics to simplify and accelerate their clinical trial supply while achieving high-quality material.
-
Technology To Overcome Absorption Hurdles And Solubility Limitations
3/6/2024
For poorly soluble drugs, overcoming absorption hurdles can hinder development. Explore a solution that empowers researchers to overcome solubility limitations and accelerate drug development.
-
Strategies For Scaling Up mRNA Manufacturing
4/11/2022
The clinical promise of mRNA therapeutics and vaccines is clear, but compared to monoclonal antibodies or viral vectors, their novelty also brings new challenges to the manufacturing process.
-
A Conceptual Overview Of The BioSMB MCC Platform
6/7/2021
In this video, our technology expert Jason Forte describes how the BioSMB system offers 3-5 fold increase in productivity, yielding up to 80% savings on chromatography resin costs with minimal disruption to the accepted ways of doing chromatography today.
-
Challenges Of The IVT Reaction In mRNA Production
2/24/2023
mRNA synthesizes from the plasma template in the in vitro transcription (IVT) step. Learn tips from a principal scientist for optimizing the IVT step of mRNA production and purification.
-
Redefine Your Oligonucleotide Manufacturing
4/22/2025
Streamline oligo production and scale confidently. Explore high-performing, purpose-built automated equipment designed to ensure safety, efficiency, and purity, from synthesis through concentration.
-
Scaling Up A Revolutionary Amorphous Solid Dispersion Platform
3/19/2024
Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.
-
Accelerating Progress: Key Considerations For CDMOs To Maximize Productivity And Scalability
6/29/2021
Due to the urgent demand for vaccines and treatments, the biopharmaceutical industry is experiencing disruptive changes and increased demand on resources that are requiring a significant operational transformation. To accelerate the delivery of life-saving therapeutics, it is essential to evaluate effective ways to maximize efficiencies and increase capacity while minimizing risk. Flexibility is critical in bioprocessing today to stay up to speed with the quickly shifting needs of the industry.
-
CESS Technology
10/20/2020
Learn how the award-winning CESS® technology can be used in Nanoforming™ future medicines to increase bioavailability for molecules with poor solubility.